Le cluster Agoniste - Récepteur dopaminergique
| 000147 (2001) | Wei Le [États-Unis] ; Joseph Jankovic [États-Unis] | Are dopamine receptor agonists neuroprotective in Parkinson's disease? |
| 000138 (2001) | S Boyce [Royaume-Uni] ; N Rupniak [Royaume-Uni] ; M Steventon [Royaume-Uni] ; S Iversen [Royaume-Uni] | Differential effects of D1 and D2 agonists in MPTP-treated primates: Functional implications for Parkinson's disease |
| 000170 (1999) | W Ondo [États-Unis] ; C Hunter [États-Unis] ; M Almaguer [États-Unis] ; S Gancher [États-Unis] ; J Jankovic [États-Unis] | Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease |
| 000174 (1999) | W Ondo [États-Unis] ; C Hunter [États-Unis] ; M Almaguer [États-Unis] ; J Jankovic [États-Unis] | A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease |
| 000208 (1985) | J Jankovic | Long-term use of dopamine agonists in Parkinson's disease |
| 000112 (2002) | William Ondo [États-Unis] ; Joel Levy [États-Unis] ; Kevin Dat [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic-induced hallucinations |
| 000124 (2001) | P Hanna [États-Unis] ; L Ratkos [États-Unis] ; W Ondo [États-Unis] ; J Jankovic [États-Unis] | Switching from pergolide to pramipexole in patients with Parkinson's disease |
| 000156 (2000) | Joseph Jankovic [États-Unis] | Parkinson's disease therapy : Tailoring choices for early and late disease, young and old patients |
| 000161 (2000) | Joseph Jankovic [États-Unis] | Complications and limitations of drug therapy for Parkinson's disease |
| 000078 (2005) | Katherine Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 000079 (2005) | Ron Tintner [États-Unis] ; Prasad Manian [États-Unis] ; Polly Gauthier [États-Unis] ; Joseph Jankovic [États-Unis] | Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease |
| 000089 (2005) | TIANHONG PAN [États-Unis] ; WENJIE XIE [États-Unis] ; Joseph Jankovic [États-Unis] ; WEIDONG LE [États-Unis] | Biological effects of pramipexole on dopaminergic neuron-associated genes : relevance to neuroprotection |
| 000099 (2003) | TIANHONG PAN [États-Unis] ; Joseph Jankovic [États-Unis] ; WEIDONG LE [États-Unis] | Potential therapeutic properties of green tea polyphenols in Parkinson's disease |
| 000121 (2001) | Philippe Damier [France] ; Jean Houeto [France] ; Boulos Bejjani [Liban] ; Isabelle Arnulf [France] ; Anne Bonnet [France] ; Malika Miloudy [France] ; Yves Agid [France] | The role of the pallidum in Parkinson's disease: Gait lessons from pallidal stimulation |
| 000136 (2001) | Joseph Jankovic [États-Unis] ; Eugene Lai [États-Unis] ; William Ondo [États-Unis] ; Deborah Roberts [États-Unis] ; Sharon Olson [États-Unis] ; Joachim Krauss [Allemagne] ; Robert Grossman [États-Unis] | Effects of pallidotomy on gait and balance |
| This area was generated with Dilib version V0.6.19. |  |